DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vyvanse (Lisdexamfetamine) - Abnormal Behaviour - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Abnormal Behaviour (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vyvanse (Lisdexamfetamine) where reactions include abnormal behaviour. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-11

Patient: male, weighing 31.7 kg (69.8 pounds)

Reactions: Product Quality Issue, Initial Insomnia, Condition Aggravated, Abnormal Behaviour, Headache, Self Injurious Behaviour, Tremor, Affective Disorder, Mood Altered, Dizziness, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-06

Patient: male, weighing 31.7 kg (69.8 pounds)

Reactions: Product Quality Issue, Initial Insomnia, Condition Aggravated, Abnormal Behaviour, Headache, Self Injurious Behaviour, Tremor, Affective Disorder, Mood Altered, Dizziness, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in 14 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22

Patient: 14 year old male, weighing 74.8 kg (164.7 pounds)

Reactions: Mania, Irritability, Agitation, Drug Ineffective, Abnormal Behaviour, Anger, Depression, Aggression

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Adderall 30
    Dosage: 1 day po
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder

Vyvanse
    Dosage: 1 day po
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder



Possible Vyvanse side effects in 6 year old female

Reported by a consumer/non-health professional from United States on 2012-02-23

Patient: 6 year old female

Reactions: Abnormal Behaviour, Hallucination

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in 8 year old female

Reported by a pharmacist from Canada on 2012-01-31

Patient: 8 year old female, weighing 23.0 kg (50.6 pounds)

Reactions: Grandiosity, Impulsive Behaviour, Suicidal Ideation, Speech Disorder, Physical Abuse, Hypersexuality, Anger, Self-Injurious Ideation, Condition Aggravated, Abnormal Behaviour, Verbal Abuse, Aggression, Irritability, Euphoric Mood, Insomnia, Sexual Dysfunction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vyvanse

Other drugs received by patient: Melatonin



Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-19

Patient: male, weighing 23.9 kg (52.7 pounds)

Reactions: Agitation, Dyskinesia, Abnormal Behaviour, Decreased Interest, Convulsion, Anxiety, Panic Attack, Social Avoidant Behaviour, Hallucination, Visual, Dysuria, Screaming, Mood Swings, Decreased Appetite, Crying

Drug(s) suspected as cause:
Vyvanse
    Dosage: 20 mg once oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2011-11-23
    End date: 2011-12-20

Vyvanse
    Dosage: 20 mg once oral
    Administration route: Oral
    Indication: Autism
    Start date: 2011-11-23
    End date: 2011-12-20



Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-12

Patient: male

Reactions: Weight Increased, TIC, Abnormal Behaviour

Drug(s) suspected as cause:
Vyvanse
    Indication: Product Used FOR Unknown Indication

Concerta
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder

Unknown Multiple Medication
    Indication: Product Used FOR Unknown Indication



Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-03

Patient: male, weighing 59.0 kg (129.7 pounds)

Reactions: Abnormal Behaviour, Mental Status Changes, Aggression, Suicidal Ideation, Hostility, Irritability, Psychotic Disorder, Bipolar Disorder, Expressive Language Disorder, Mental Disorder, Depression, Violence-Related Symptom, Tension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Concerta
    Administration route: Oral
    Start date: 2011-10-15

Concerta
    Administration route: Oral
    Start date: 2011-10-12

Concerta
    Administration route: Oral
    Start date: 2011-10-15

Concerta
    Administration route: Oral
    End date: 2011-09-12

Vyvanse
    Start date: 2011-09-20

Concerta
    Administration route: Oral
    End date: 2011-09-12

Concerta
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2011-10-13

Vyvanse
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-19

Concerta
    Administration route: Oral
    Start date: 2011-10-14

Concerta
    Administration route: Oral
    Start date: 2011-10-16

Vyvanse
    Start date: 2011-09-21

Concerta
    Administration route: Oral
    Indication: Depression
    Start date: 2011-10-13

Concerta
    Administration route: Oral
    Start date: 2011-10-16

Concerta
    Administration route: Oral
    Start date: 2011-10-12

Concerta
    Administration route: Oral
    Start date: 2011-10-14

Other drugs received by patient: Lithium Carbonate; Lithium Carbonate



Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-27

Patient: male, weighing 59.0 kg (129.7 pounds)

Reactions: Mental Status Changes, Abnormal Behaviour, Aggression, Suicidal Ideation, Hostility, Irritability, Psychotic Disorder, Bipolar Disorder, Expressive Language Disorder, Mental Disorder, Depression, Violence-Related Symptom, Tension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Concerta
    Administration route: Oral
    Start date: 2011-10-16

Concerta
    Administration route: Oral
    Start date: 2011-10-12

Concerta
    Administration route: Oral
    Start date: 2011-10-14

Concerta
    Administration route: Oral
    Start date: 2011-10-15

Vyvanse
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-19

Vyvanse
    Start date: 2011-09-20

Concerta
    Administration route: Oral
    End date: 2011-09-12

Concerta
    Administration route: Oral
    Indication: Depression
    Start date: 2011-10-13

Concerta
    Administration route: Oral
    End date: 2011-09-12

Concerta
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2011-10-13

Vyvanse
    Start date: 2011-09-21

Concerta
    Administration route: Oral
    Start date: 2011-10-12

Concerta
    Administration route: Oral
    Start date: 2011-10-16

Concerta
    Administration route: Oral
    Start date: 2011-10-15

Concerta
    Administration route: Oral
    Start date: 2011-10-14

Other drugs received by patient: Lithium; Lithium



Possible Vyvanse side effects in male

Reported by a consumer/non-health professional from United States on 2011-11-18

Patient: male

Reactions: Abnormal Behaviour, Drug Interaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakote
    Dosage: unk, unknown
    Indication: Product Used FOR Unknown Indication

Vyvanse
    Dosage: unk unk, unknown

Vyvanse
    Dosage: 70 mg, unknown
    Indication: Product Used FOR Unknown Indication

Risperidone
    Dosage: unk, unknown
    Indication: Product Used FOR Unknown Indication



Possible Vyvanse side effects in 7 year old male

Reported by a physician from United States on 2011-10-06

Patient: 7 year old male, weighing 30.4 kg (66.9 pounds)

Reactions: Completed Suicide, Abnormal Behaviour, Impulsive Behaviour, Aggression

Adverse event resulted in: death

Drug(s) suspected as cause:
Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Aggression
    Start date: 2009-03-18
    End date: 2009-04-16

Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Impulsive Behaviour
    Start date: 2009-03-18
    End date: 2009-04-16

Lexapro
    Dosage: 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2009-02-03
    End date: 2009-03-18

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012